跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A-36
首页
药物
A-36
A-36
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
HPYY(1-36) having a beta-homoarginine substitution at position 35
申请人: NOVO NORDISK AS
优先权: 2014
US
A COMPOSITION COMPRISING IL-36 AND/OR IL-18 FOR USE IN TREATING OCULAR DISORDERS
申请人: PROVOST FELLOWS FOUND SCHOLARS & OTHER MEMBERS BOARD COLLEGE HOLY & UND
优先权: 2021
EP
US
WO
5 件公开
A novel polypeptide-nicotinamide adenine deoxydinucleotide dependent leukotriene B412-hydroxydehydrogenase 36 and polynucleotide for coding this polypeptide
申请人: BODE GENE DEV CO LTD SHANGHAI
优先权: 2000
CN
US
2 件公开
ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR ICHTHYOSIS
申请人: ANAPTYSBIO INC
优先权: 2020
CN
EP
US
WO
5 件公开
Traditional Chinese medicine composition for cancer cells
申请人: JIAOZHOU SHENGFU TRADITIONAL CHINESE MEDICINE CLINIC SHOP
优先权: 2022
CN
Acupuncture medicine liquid for treating dysmenorrhea and preparation method thereof
申请人: ZHANG YANG
优先权: 2016
CN
Mouse truncated IL-36 gamma protein and preparation method thereof
申请人: AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIV
优先权: 2020
CN
2 件公开
小肽GLP-1(28-36)amide在制备用于防治稻瘟病的药物中的应用和方法
申请人: 湘湖实验室(农业浙江省实验室)
优先权: 2025
CN
2 件公开
药物
反馈